GlassScriptPhysician profile
Christopher Zambrano
NPI 1184990525
$39,176.87
in general payments reported to CMS, 2019-2025
13 companies · $11K in 2025
The $11K reported for 2025 was more than what 90% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $623 · 2020: $2,188 · 2021: $13K · 2022: $4,419 · 2023: $5,786 · 2024: $1,785 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,578 · Consulting Fee: $5,600 · Travel and Lodging: $3,344 · Food and Beverage: $1,367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,577.97 |
| Consulting Fee | $5,600.00 |
| Travel and Lodging | $3,344.36 |
| Food and Beverage | $1,366.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $23,003.48 | 2021-2025 | |
| Atricure, INC. | $13,819.16 | 2020-2025 | Synergy Ablation System, Epi-Ease Epicardial Access System, Epi-Sense Guided Coagulation System With Visitrax |
| Medtronic Vascular, INC. | $1,278.37 | 2019-2020 | |
| Edwards Lifesciences Corporation | $607.46 | 2019-2025 | Inspiris Resilia Aortic Valve |
| Becton, Dickinson and Company | $128.03 | 2025 | Surgiphor, Arista |
| Galvanize Therapeutics, INC | $106.62 | 2025 | Aliya System |
| Stryker Corporation | $54.81 | 2025 | Na |
| Dilon Technologies, INC. | $50.95 | 2025 | Hemoblast Bellows |
| Abiomed | $30.43 | 2025 | |
| Ethicon US, LLC | $29.86 | 2025 | Ethicon, Stratafix, Vistaseal |
| Boston Scientific Corporation | $24.91 | 2019 | |
| Novartis Pharmaceuticals Corporation | $23.14 | 2023 | |
| Medtronic, INC. | $19.65 | 2025 | Corevalve Evolut R |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Zambrano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.